{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:40:30Z","timestamp":1792820430664,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.meegid.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T20:19:39Z","timestamp":1509567579000},"page":"75-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Overlapping CD8 + and CD4 + T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach"],"prefix":"10.1016","volume":"56","author":[{"given":"Utpal Kumar","family":"Adhikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mizanur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2017.10.022_bb0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.12656","article-title":"From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein","volume":"149","author":"Alam","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.meegid.2017.10.022_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/278197","article-title":"A highly conserved GEQYQQLR epitope has been identified in the nucleoprotein of Ebola virus by using an in silico approach","author":"Ali","year":"2015","journal-title":"Adv. Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12539-015-0023-0","article-title":"A computational approach for designing a universal epitope-based peptide vaccine against Nipah virus","volume":"7","author":"Ali","year":"2015","journal-title":"Interdiscip. Sci."},{"key":"10.1016\/j.meegid.2017.10.022_bb0020","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.2010.09-0289","article-title":"Prediction, assessment of the Rift Valley fever activity in east and southern Africa 2006\u20132008 and possible vector control strategies","author":"Anyamba","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2017.10.022_bb0025","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk factors for severe Rift Valley fever infection in Kenya, 2007","author":"Anyangu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2017.10.022_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2017.10.022_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.antiviral.2016.07.005","article-title":"Rift Valley fever virus: unanswered questions","volume":"132","author":"Bird","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2017.10.022_bb0045","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.meegid.2017.10.022_bb0050","article-title":"Molecular biology of Rift Valley fever virus","author":"Bouloy","year":"2010","journal-title":"Open Virol. J."},{"key":"10.1016\/j.meegid.2017.10.022_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/35014520","article-title":"Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand","volume":"405","author":"Boyington","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2017.10.022_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2105-8-361","article-title":"Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines","volume":"8","author":"Bui","year":"2007","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0080","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0085","doi-asserted-by":"crossref","DOI":"10.3201\/eid1902.120941","article-title":"Rift Valley fever and a new paradigm of research and development for zoonotic disease control","author":"Dar","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0090","article-title":"In silico-based vaccine design against Ebola virus glycoprotein","author":"Dash","year":"2017","journal-title":"Adv. Appl. Bioinforma. Chem."},{"key":"10.1016\/j.meegid.2017.10.022_bb0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"issue":"5","key":"10.1016\/j.meegid.2017.10.022_bb0100","first-page":"941","article-title":"Rainfall and epizootic Rift Valley fever","volume":"63","author":"Davies","year":"1985","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.meegid.2017.10.022_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 inducing peptides","author":"Dhanda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/1348-0421.12436","article-title":"Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer","volume":"60","author":"Dhiman","year":"2016","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.meegid.2015.10.012","article-title":"Computational elucidation of potential antigenic CTL epitopes in Ebola virus","volume":"36","author":"Dikhit","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.meegid.2016.08.037","article-title":"Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: a first step towards vaccine development","volume":"45","author":"Dikhit","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00337-13","article-title":"Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4(+) T cell and virus-specific antibody responses","author":"Dodd","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0135","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0426","article-title":"After 2015: infectious diseases in a new era of health and development","author":"Dye","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.meegid.2017.10.022_bb0145","doi-asserted-by":"crossref","DOI":"10.1089\/vbz.2014.1650","article-title":"A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep","author":"Faburay","year":"2014","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep27719","article-title":"A recombinant Rift Valley fever virus glycoprotein subunit vaccine confers full protection against Rift Valley fever challenge in sheep","author":"Faburay","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.meegid.2017.10.022_bb0155","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.vaccine.2006.03.009","article-title":"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects","volume":"24","author":"Firbas","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.immunol.17.1.369","article-title":"Structural basis of T cell recognition","volume":"17","author":"Garcia","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cll.2017.01.004","article-title":"Rift Valley fever","volume":"37","author":"Hartman","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.meegid.2017.10.022_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001229","article-title":"The 2007 Rift Valley fever outbreak in Sudan","author":"Hassan","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0175","article-title":"Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding","author":"He","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.meegid.2017.10.022_bb0180","series-title":"Rift Valley Fever Virus NSs Protein Promotes Post-Transcriptional Downregulation of Protein Kinase PKR and Inhibits eIF2\u03b1 Phosphorylation","author":"Ikegami","year":"2009"},{"key":"10.1016\/j.meegid.2017.10.022_bb0185","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14760584.2017.1321482","article-title":"Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate","volume":"16","author":"Ikegami","year":"2017","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.meegid.2017.10.022_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","author":"Ikegami","year":"2011","journal-title":"Viruses."},{"key":"10.1016\/j.meegid.2017.10.022_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.79.9.5606-5615.2005","article-title":"Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a Minigenome system","author":"Ikegami","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0200","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2217\/fvl.12.95","article-title":"A computational assay to design an epitope-based peptide vaccine against chikungunya virus","volume":"7","author":"Islam","year":"2012","journal-title":"Futur. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0205","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1016\/j.vaccine.2009.09.060","article-title":"A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults","volume":"27","author":"Jin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.meegid.2017.05.022","article-title":"Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach","volume":"53","author":"Kashyap","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40005-015-0205-0","article-title":"In silico prediction of epitopes for Chikungunya viral strains","volume":"45","author":"Kori","year":"2015","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.meegid.2017.10.022_bb0220","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0225","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden markov model: application to complete genomes11 Edited by F. Cohen","volume":"305","author":"Krogh","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley fever virus cDNA constructs","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2017.10.022_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1440-1711.2005.01405.x","article-title":"Activated mouse T cells downregulate, process and present their surface TCR to cognate anti-idiotypic CD4+ T cells","volume":"84","author":"Lal","year":"2006","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pervac.2011.05.005","article-title":"Vaccine development","volume":"1","author":"Leroux-Roels","year":"2011","journal-title":"Perspect. Vaccinol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","article-title":"Rift Valley fever: an emerging mosquito-borne disease","volume":"61","author":"Linthicum","year":"2016","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/vim.2013.0135","article-title":"Conserved peptides containing overlapping CD4+ and CD8+ T-cell epitopes in the H1N1 influenza virus: an immunoinformatics approach","volume":"27","author":"Lohia","year":"2014","journal-title":"Viral Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0260","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1089\/vim.2015.0060","article-title":"Identification of conserved peptides comprising multiple T cell epitopes of matrix 1 protein in H1N1 influenza virus","volume":"28","author":"Lohia","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"L\u00f3pez-Gil","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0270","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4161\/hv.6.7.11761","article-title":"Rift Valley fever virus: an unrecognized emerging threat?","volume":"6","author":"Mandell","year":"2010","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.meegid.2017.10.022_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4172\/2157-2526.1000108","article-title":"Rift Valley fever virus: a real bioterror threat","volume":"2","author":"Mandell","year":"2011","journal-title":"J. Bioterror. Biodef."},{"key":"10.1016\/j.meegid.2017.10.022_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"Mandell","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.meegid.2017.10.022_bb0285","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1016\/j.vaccine.2015.08.020","article-title":"Rift Valley fever virus: a review of diagnosis and vaccination, and implications for emergence in Europe","volume":"33","author":"Mansfield","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001808","article-title":"Exploratory space-time analyses of Rift Valley fever in South Africa in 2008\u20132011","author":"M\u00e9tras","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0295","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/bioinformatics\/17.7.646","article-title":"Evaluation of methods for the prediction of membrane spanning regions","volume":"17","author":"Moller","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.meegid.2017.10.022_bb0300","doi-asserted-by":"crossref","DOI":"10.3201\/eid1912.130593","article-title":"Rift Valley fever in Namibia, 2010","author":"Monaco","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0305","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.meegid.2017.10.022_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005861","article-title":"AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins","volume":"4","author":"Muh","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.10.022_bb0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2017.10.022_bb0320","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley fever virus","volume":"385","author":"N\u00e4slund","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.meegid.2017.10.022_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers3043991","article-title":"Peptide based vaccine approaches for cancer\u2014a novel approach using a WT-1 synthetic long peptide and the IRX-2 immunomodulatory regimen","author":"Naylor","year":"2011","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.meegid.2017.10.022_bb0330","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.2010.09-0288","article-title":"An investigation of a major outbreak of Rift Valley fever in Kenya: 2006\u20132007","author":"Nguku","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2017.10.022_bb0335","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0340","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5245021","article-title":"Emerging and neglected infectious diseases: insights, advances, and challenges","author":"Nii-Trebi","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.meegid.2017.10.022_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.meegid.2017.10.022_bb0350","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/21645515.2015.1094595","article-title":"Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production","volume":"12","author":"Oyarz\u00fan","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.meegid.2017.10.022_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method","author":"Peters","year":"2005","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0360","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2009.0248","article-title":"Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus","volume":"10","author":"Pichlmair","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0365","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: an open bioinformatics database and analysis resource for virology research","volume":"40","author":"Pickett","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2017.10.022_bb0370","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against rift valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.81","article-title":"The risk of Rift Valley fever virus introduction and establishment in the United States and European Union","author":"Rolin","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.meegid.2017.10.022_bb0380","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.4049\/jimmunol.177.6.3884","article-title":"Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen","volume":"177","author":"Rosloniec","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0385","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/402492","article-title":"Prediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of Nipah virus using in silico approach","author":"Sakib","year":"2014","journal-title":"Adv. Bioinforma."},{"key":"10.1016\/j.meegid.2017.10.022_bb0400","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.meegid.2017.10.022_bb0405","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD approach for peptide and miniprotein structure prediction","volume":"10","author":"Shen","year":"2014","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.meegid.2017.10.022_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144475","article-title":"Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.10.022_bb0415","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/CVI.00468-09","article-title":"Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes","volume":"17","author":"Sominskaya","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0420","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3201\/eid2002.131000","article-title":"Rift Valley fever outbreak, southern Mauritania, 2012","volume":"20","author":"Sow","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw149","article-title":"Widespread Rift Valley fever emergence in Senegal in 2013\u20132014","author":"Sow","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.meegid.2017.10.022_bb0430","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0435","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-7-351","article-title":"Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development","author":"Stanekov\u00e1","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2017.10.022_bb0440","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/14760584.2015.955478","article-title":"Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases","volume":"14","author":"Terry","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.meegid.2017.10.022_bb0445","doi-asserted-by":"crossref","first-page":"W288","DOI":"10.1093\/nar\/gks419","article-title":"PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides","volume":"40","author":"Th\u00e9venet","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2017.10.022_bb0450","article-title":"Multiple sequence alignment using ClustalW and ClustalX","author":"Thompson","year":"2002","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.meegid.2017.10.022_bb0455","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.meegid.2017.10.022_bb0460","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tibtech.2007.12.006","article-title":"Computer-aided biotechnology: from immuno-informatics to reverse vaccinology","volume":"26","author":"Vivona","year":"2008","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0465","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2006.11.005","article-title":"Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA","volume":"140","author":"van Vuren","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2017.10.022_bb0470","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2017.10.022_bb0475","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00476-06","article-title":"NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture","author":"Won","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0480","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.10.022_bb0485","article-title":"The Nucleocapsid protein of Rift Valley fever virus is a potent human CD8(+) T cell antigen and elicits memory responses","author":"Xu","year":"2013","journal-title":"PLoS One"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817303726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817303726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T06:37:03Z","timestamp":1719556623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134817303726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":97,"alternative-id":["S1567134817303726"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2017.10.022","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}